MONTE ROSA THERAPEUTICS INC

Ticker: GLUE CUSIP: 61225M102 Class: Common Stock

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 123,000 Value ($000) $1,929 Avg Close $13.48 Range $7.24 - $19.17
Q3 2025
Shares 72,095 Value ($000) $534 Avg Close $5.30 Range $4.12 - $7.51
Q2 2025
Shares 108,241 Value ($000) $488 Avg Close $4.46 Range $3.50 - $5.47
Q1 2025
Shares 91,514 Value ($000) $425 Avg Close $6.13 Range $4.50 - $7.46
Q4 2024
Shares 59,399 Value ($000) $412 Avg Close $7.50 Range $4.59 - $12.40
Q3 2024
Shares 25,333 Value ($000) $134 Avg Close $5.05 Range $3.52 - $7.05
Q2 2024
Shares 23,294 Value ($000) $87 Avg Close $5.10 Range $3.21 - $8.22
Q1 2024
Shares 41,173 Value ($000) $290 Avg Close $5.93 Range $4.18 - $8.84
Q4 2023
Shares 37,948 Value ($000) $214 Avg Close $3.92 Range $2.44 - $6.40
Q3 2023
Shares 23,309 Value ($000) $112 Avg Close $6.44 Range $4.47 - $7.90
Q2 2023
Shares 23,775 Value ($000) $163 Avg Close $6.47 Range $4.40 - $8.83
Q1 2023
Shares 10,406 Value ($000) $81 Avg Close $6.95 Range $5.74 - $8.57
Q4 2022
Shares 9,247 Value ($000) $70 Avg Close $8.33 Range $6.51 - $10.96
Q1 2022
Shares 29,408 Value ($000) $412 Avg Close $13.88 Range $9.82 - $21.56
Q4 2021
Shares 3,260 Value ($000) $67 Avg Close $20.94 Range $15.67 - $27.57